bluebird bio Announces Pricing of Public Offering of Common Stock Read more about bluebird bio Announces Pricing of Public Offering of Common Stock
bluebird bio Announces Proposed Public Offering of Common Stock Read more about bluebird bio Announces Proposed Public Offering of Common Stock
Kite Pharma and bluebird bio Announce Strategic Collaboration to Advance Second Generation TCR Cell Therapy Products to Treat HPV-Associated Cancers Read more about Kite Pharma and bluebird bio Announce Strategic Collaboration to Advance Second Generation TCR Cell Therapy Products to Treat HPV-Associated Cancers
Philip Gregory, D. Phil., Joins bluebird bio as Chief Scientific Officer Read more about Philip Gregory, D. Phil., Joins bluebird bio as Chief Scientific Officer
bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 Study at EHA Read more about bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 Study at EHA
bluebird bio Completes NIH RAC Review of HGB-208 Pediatric Study Protocol Read more about bluebird bio Completes NIH RAC Review of HGB-208 Pediatric Study Protocol
Celgene and bluebird bio to Develop Anti-BCMA Product Candidates; bluebird bio Regains Rights to CAR T Programs Outside of BCMA Read more about Celgene and bluebird bio to Develop Anti-BCMA Product Candidates; bluebird bio Regains Rights to CAR T Programs Outside of BCMA
bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy Read more about bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
bluebird bio Announces Participation at the Jefferies 2015 Global Healthcare Conference Read more about bluebird bio Announces Participation at the Jefferies 2015 Global Healthcare Conference
bluebird bio to Present LentiGlobin Clinical Data at 20th Congress of European Hematology Association Read more about bluebird bio to Present LentiGlobin Clinical Data at 20th Congress of European Hematology Association